Cargando…

Updates in the Management of Renal Cell Carcinoma

At JADPRO Live Virtual 2021, advanced practitioner experts reviewed clinical updates in the treatment of renal cell carcinoma, key patient counseling and monitoring considerations, and best practices to manage adverse events associated with therapies for renal cell carcinoma.

Detalles Bibliográficos
Autores principales: Hanna, Kirollos S., Lim, Zita D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126346/
https://www.ncbi.nlm.nih.gov/pubmed/35663157
http://dx.doi.org/10.6004/jadpro.2022.13.3.27
_version_ 1784712107183308800
author Hanna, Kirollos S.
Lim, Zita D.
author_facet Hanna, Kirollos S.
Lim, Zita D.
author_sort Hanna, Kirollos S.
collection PubMed
description At JADPRO Live Virtual 2021, advanced practitioner experts reviewed clinical updates in the treatment of renal cell carcinoma, key patient counseling and monitoring considerations, and best practices to manage adverse events associated with therapies for renal cell carcinoma.
format Online
Article
Text
id pubmed-9126346
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-91263462022-06-04 Updates in the Management of Renal Cell Carcinoma Hanna, Kirollos S. Lim, Zita D. J Adv Pract Oncol Meeting Reports At JADPRO Live Virtual 2021, advanced practitioner experts reviewed clinical updates in the treatment of renal cell carcinoma, key patient counseling and monitoring considerations, and best practices to manage adverse events associated with therapies for renal cell carcinoma. Harborside Press LLC 2022-04 2022-05-23 /pmc/articles/PMC9126346/ /pubmed/35663157 http://dx.doi.org/10.6004/jadpro.2022.13.3.27 Text en © 2022 Harborside™ https://creativecommons.org/licenses/by-nc-nd/3.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Reports
Hanna, Kirollos S.
Lim, Zita D.
Updates in the Management of Renal Cell Carcinoma
title Updates in the Management of Renal Cell Carcinoma
title_full Updates in the Management of Renal Cell Carcinoma
title_fullStr Updates in the Management of Renal Cell Carcinoma
title_full_unstemmed Updates in the Management of Renal Cell Carcinoma
title_short Updates in the Management of Renal Cell Carcinoma
title_sort updates in the management of renal cell carcinoma
topic Meeting Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126346/
https://www.ncbi.nlm.nih.gov/pubmed/35663157
http://dx.doi.org/10.6004/jadpro.2022.13.3.27
work_keys_str_mv AT hannakirolloss updatesinthemanagementofrenalcellcarcinoma
AT limzitad updatesinthemanagementofrenalcellcarcinoma